The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
For guest writer Aranzazu Calzado, there's nothing like a wall to remind her that having something to lean on is not about ...
4don MSN
Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...
A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
MedPage Today on MSN
Multiple Sclerosis Risk May Start Before Birth
Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...
ScienceAlert on MSN
Multiple sclerosis may have two distinct subtypes, scientists discover
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
News-Medical.Net on MSN
Epstein-Barr virus together with a gene variant contributes to onset of multiple sclerosis
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role.
Elsa Mendoza has been living with the disease for years. Here's more on her battle and what it means to have Multiple Sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results